品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
源叶 | S81258-10mg | 10mg | 厂家现货 | 1234480-50-2 |
XMD8-92 2-[[2-ethoxy-4-(4-hydroxy-1-... |
99% |
|
|
源叶 | S81258-50mg | 50mg | 厂家现货 | 1234480-50-2 |
XMD8-92 2-[[2-ethoxy-4-(4-hydroxy-1-... |
99% |
|
|
源叶 | S81256-100mg | 100mg | 厂家现货 | 1234480-50-2 |
LY2606368 (dihydrochloride) LY2606368 (dihydrochloride) |
98% |
|
|
源叶 | S81258-1mg | 1mg | 厂家现货 | 1234480-50-2 |
XMD8-92 XMD8-92 |
99% |
|
|
源叶 | S81258-5mg | 5mg | 厂家现货 | 1234480-50-2 |
XMD8-92 2-[[2-ethoxy-4-(4-hydroxy-1-... |
99% |
|
|
阿拉丁 | X125609-10mg | 10mg | 现货 | 1234480-50-2 |
XMD8-92,ERK5 / BMK1抑制剂 XMD8-92 |
≥97% |
|
|
阿拉丁 | X125609-50mg | 50mg | 现货 | 1234480-50-2 |
XMD8-92,ERK5 / BMK1抑制剂 XMD8-92 |
≥97% |
|
|
阿拉丁 | X125609-100mg | 100mg | 现货 | 1234480-50-2 |
XMD8-92,ERK5 / BMK1抑制剂 XMD8-92 |
≥97% |
|
|
阿拉丁 | X125609-1mg | 1mg | 现货 | 1234480-50-2 |
XMD8-92,ERK5 / BMK1抑制剂 XMD8-92 |
≥97% |
|
|
阿拉丁 | X125609-5mg | 5mg | 现货 | 1234480-50-2 |
XMD8-92,ERK5 / BMK1抑制剂 XMD8-92 |
≥97% |
|
|
阿拉丁 | X421018-1ml | 1ml | 期货,请咨询 | 1234480-50-2 |
XMD8-92 XMD8-92 |
10mM in DMSO |
|
|
麦克林 | X872633-5mg | 5mg | 厂家现货 | 1234480-50-2 |
XMD8-92 XMD8-92 |
99% |
|
|
麦克林 | X872633-1mg | 1mg | 厂家现货 | 1234480-50-2 |
XMD8-92 XMD8-92 |
99% |
|
|
麦克林 | X872633-10mg | 10mg | 厂家现货 | 1234480-50-2 |
XMD8-92 XMD8-92 |
99% |
|
|
麦克林 | X872633-50mg | 50mg | 厂家现货 | 1234480-50-2 |
XMD8-92 XMD8-92 |
99% |
|
|
毕得 | BD418087-10mg | 10mg | 现货 | 1234480-50-2 |
2-((2-乙氧基-4-(4-羟基哌啶-1-基)苯基)氨... 2-((2-Ethoxy-4-(4-hydroxypip... |
98% |
|
|
毕得 | BD418087-50mg | 50mg | 现货 | 1234480-50-2 |
2-((2-乙氧基-4-(4-羟基哌啶-1-基)苯基)氨... 2-((2-Ethoxy-4-(4-hydroxypip... |
98% |
|
|
毕得 | BD418087-100mg | 100mg | 现货 | 1234480-50-2 |
2-((2-乙氧基-4-(4-羟基哌啶-1-基)苯基)氨... 2-((2-Ethoxy-4-(4-hydroxypip... |
98% |
|
|
毕得 | BD418087-5mg | 5mg | 现货 | 1234480-50-2 |
2-((2-乙氧基-4-(4-羟基哌啶-1-基)苯基)氨... 2-((2-Ethoxy-4-(4-hydroxypip... |
98% |
|
|
毕得 | BD418087-25mg | 25mg | 现货 | 1234480-50-2 |
2-((2-乙氧基-4-(4-羟基哌啶-1-基)苯基)氨... 2-((2-Ethoxy-4-(4-hydroxypip... |
98% |
|
|